| Old Articles: <Older 1021-1030 Newer> |
 |
The Motley Fool October 10, 2005 Stephen D. Simpson |
Does Slow + Slow Equal "Faster"? The combination of two slow-growing life insurance and annuity companies wouldn't seem to promise great future growth. However, the deal between Lincoln and Jefferson Pilot may be different. Investors, take note.  |
Registered Rep. October 1, 2005 Kristen French |
Ducking the VA Storm Raymond James outlined plans to cut fees and commissions, and remove some conflicts of interest in variable annuity marketing. The broker/dealer has notified insurers that if they wish to sell on its platform they must adhere to new design requirements.  |
Registered Rep. October 1, 2005 Janet Arrowood |
The Advisor's Safety Net: LTC Insurance While boomer-aged clients are in the process of shifting from asset-accumulation to asset-withdrawal mode, advisors need to discuss long-term care insurance.  |
Registered Rep. October 1, 2005 Matt Barthel |
Insurance and the Generation Gap Reps historically have been reluctant to sell life insurance because of the steep learning curve associated with the products, and there is evidence that many still are hesitant to put forth the effort necessary to grasp the products' nuances.  |
Managed Care September 2005 Martin Sipkoff |
The Private Sector Can, Should, and Will Help Solve the Problem of the Uninsured WellPoint Chairman Leonard Schaeffer and other health plan leaders believe they can help with the chronic societal issue of uninsured Americans.  |
Managed Care September 2005 Ed Silverman |
No Easy Fit For Specialty Hospitals Insurers worry that specialty hospitals will ultimately increase costs at nearby community hospitals  |
Managed Care September 2005 John Carroll |
Plans Struggle for Control of Specialty Pharma Costs Biotech drugs are a quickly growing component of health plan budgets. Here are the latest management techniques.  |
Managed Care September 2005 |
There's Now a Correct Method For Defining ROI in Disease Management Health care consultant Al Lewis, the godfather of disease management, talks about how the industry went wrong, and is now going right, in describing its own value to health plans, public employers, and the government.  |
Managed Care September 2005 John Carroll |
DM Industry Confident It Can Hit Medicare Goals Though there are challenges to serving the elderly, the movers and shakers of disease management say that they should be able to cut costs in pilot populations by 5%.  |
Managed Care September 2005 |
New Research Throws Doubt On DM's Cost-Effectiveness Health plans and other providers of disease management services might do better to emphasize the pursuit of better outcomes, rather than guaranteed savings, a new study implies.  |
| <Older 1021-1030 Newer> Return to current articles. |